Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : SARS-CoV-2 Vaccine Recombinant
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : Yale University
Deal Size : Undisclosed
Deal Type : Collaboration
CaroGen and Yale Scientists Team to Develop a COVID-19 Vaccine
Details : CaroGen team up with Yale University School of Medicine to develop AVIDIO/SARS-CoV-2 recombinant vaccine for COVID-19.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Undisclosed
October 03, 2020
Lead Product(s) : SARS-CoV-2 Vaccine Recombinant
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : Yale University
Deal Size : Undisclosed
Deal Type : Collaboration